These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 12731728

  • 1. Ets-1 expression in vascular endothelial cells as an angiogenic and prognostic factor in colorectal carcinoma.
    Tokuhara K, Ogata Y, Nakagawa M, Shirouzu K.
    Int Surg; 2003; 88(1):25-33. PubMed ID: 12731728
    [Abstract] [Full Text] [Related]

  • 2. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R.
    Clin Cancer Res; 2005 Mar 15; 11(6):2272-84. PubMed ID: 15788677
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH.
    Eur Surg Res; 2007 Mar 15; 39(4):229-38. PubMed ID: 17446709
    [Abstract] [Full Text] [Related]

  • 4. Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma.
    Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM.
    Clin Cancer Res; 2001 Mar 15; 7(3):551-7. PubMed ID: 11297247
    [Abstract] [Full Text] [Related]

  • 5. [Expression and significance about VEGF, KDR, MMP-1, and transcription factor Ets-1 in human cervical carcinoma].
    Xu FL, Li YL, Wang ZD, Feng YJ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug 15; 25(4):396-400. PubMed ID: 12974081
    [Abstract] [Full Text] [Related]

  • 6. Altered expression of angiogenic factors in the VEGF-Ets-1 cascades in inflammatory bowel disease.
    Konno S, Iizuka M, Yukawa M, Sasaki K, Sato A, Horie Y, Nanjo H, Fukushima T, Watanabe S.
    J Gastroenterol; 2004 Oct 15; 39(10):931-9. PubMed ID: 15549445
    [Abstract] [Full Text] [Related]

  • 7. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
    Nakayama T, Ito M, Ohtsuru A, Naito S, Sekine I.
    Mod Pathol; 2001 May 15; 14(5):415-22. PubMed ID: 11353051
    [Abstract] [Full Text] [Related]

  • 8. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT, Uetake H, Takagi Y, Iida S, Higuchi T, Yasuno M, Enomoto M, Sugihara K.
    Dis Colon Rectum; 2006 Mar 15; 49(3):392-8. PubMed ID: 16474989
    [Abstract] [Full Text] [Related]

  • 9. Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells.
    Teruyama K, Abe M, Nakano T, Iwasaka-Yagi C, Takahashi S, Yamada S, Sato Y.
    J Cell Physiol; 2001 Aug 15; 188(2):243-52. PubMed ID: 11424091
    [Abstract] [Full Text] [Related]

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 15; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Ochiumi T, Tanaka S, Oka S, Hiyama T, Ito M, Kitadai Y, Haruma K, Chayama K.
    Int J Oncol; 2004 Mar 15; 24(3):539-47. PubMed ID: 14767538
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of thrombospondin-1 expression in relation to vascular endothelial growth factor and interleukin-10 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
    Kaio E, Tanaka S, Oka S, Hiyama T, Kitadai Y, Haruma K, Chayama K.
    Int J Oncol; 2003 Oct 15; 23(4):901-11. PubMed ID: 12963968
    [Abstract] [Full Text] [Related]

  • 13. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
    Tsujitani S, Saito H, Maeta Y, Yamaguchi K, Tatebe S, Kondo A, Kaibara N.
    Anticancer Res; 2004 Oct 15; 24(3b):1853-9. PubMed ID: 15274366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B.
    Breast Cancer Res Treat; 2005 Nov 15; 94(1):71-80. PubMed ID: 16142438
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
    Yasuno M, Mori T, Koike M, Takahashi K, Toi M, Takizawa T, Shimizu S, Yamaguchi T, Matsumoto H.
    Oncol Rep; 2005 Mar 15; 13(3):405-12. PubMed ID: 15706408
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.